We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+5.7%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.68B
AUM Growth
+$101M
Cap. Flow
-$193M
Cap. Flow %
-2.51%
Top 10 Hldgs %
17.01%
Holding
1,082
New
298
Increased
225
Reduced
230
Closed
304

Top Sells

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$97.3M
2
AGN
Allergan Inc
AGN
+$79.1M
3
MU icon
Micron Technology
MU
+$67M
4
HPQ icon
HP
HPQ
+$65.4M
5
BAX icon
Baxter International
BAX
+$55.7M

Sector Composition

Rank Sector Weight
1 Healthcare 21.38%
2 Financials 13.7%
3 Communication Services 11.26%
4 Technology 9.89%
5 Industrials 8.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RKUS
1076
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
-52,443
Closed -$630K
AGN
1077
DELISTED
Allergan Inc
AGN
-372,011
Closed -$79.1M
ARMH
1078
DELISTED
ARM HOLDINGS PLC ADS
ARMH
-9,255
Closed -$429K
SPN
1079
DELISTED
Superior Energy Services, Inc.
SPN
-6,956
Closed -$1.4M
AAN.A
1080
DELISTED
The Aaron's Company Inc Class A
AAN.A
-133,226
Closed -$4.07M

Similar funds

Marshall Wace's Q1 2015 Portfolio in Review

As of Q1 2015, Marshall Wace held 1,082 positions worth $7.68B, up 1.3% from $7.57B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q1 2015 filing shows 298 new, 225 increased, 230 reduced and 304 closed positions. Its largest new stake was Viatris: 845,509 shares worth $50.2M. The largest sale was T-Mobile US, an estimated $97.3M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.

  • Marshall Wace's largest Q1 2015 buy was Viatris: 845,509 shares worth $50.2M.
  • Marshall Wace added most to Allergan plc in Q1 2015, an estimated $123M increase.
  • Marshall Wace's biggest Q1 2015 reduction was T-Mobile US, cutting an estimated $97.3M.
  • Marshall Wace fully exited Allergan Inc in Q1 2015, selling an estimated $79.1M.
  • Marshall Wace's ten largest holdings make up 17% of its $7.68B portfolio in Q1 2015.
  • Marshall Wace opened 298 new positions and closed 304 in Q1 2015.
  • Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $7.68B.

Based on Marshall Wace's 13F filing for Q1 2015, filed 11 May 2015.